StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Atai Life Sciences N.V.
NasdaqGM:ATAI
Sector
Location
Market Cap
USD 587.64 M
Share Price
USD 2.75
Avg Daily Volume
1,975,701
Change (1 day)
-0.72%
Change (1 year)
116.54%
Change (YTD)
106.77%
Atai Life Sciences N.V. Market Capitalization on July 07, 2025: USD 587.64 M
Atai Life Sciences N.V. Market Capitalization is USD 587.64 M on July 07, 2025, a 178.75% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Atai Life Sciences N.V. 52-week low Market Capitalization is USD 591.91 M on July 07, 2025, which is 0.73% above the current Market Capitalization.
-
Atai Life Sciences N.V. 52-week low Market Capitalization is USD 177.61 M on July 07, 2025, which is -69.78% below the current Market Capitalization.
-
Atai Life Sciences N.V. average Market Capitalization for the last 52 weeks is USD 291.34 M.
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
MERCK Kommanditgesellschaft auf Aktien
USD 128.02
MRK.DE
-2.92
-2.23%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
MERCK Kommanditgesellschaft auf Aktien
USD 128.02
MRK.DE
-2.92
-2.23%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%